Health Condition 1: M170- Bilateral primary osteoarthritis of knee
Conditions
Interventions
Intervention1: Mudakku Vatha Ilagam: 5 gms - Oral dose
Twice a day with hot water
After food intake
Control Intervention1: Varmam Therapy
1.MuttuVarmam
2.SanthiVarmam
3.MozhiPoruthuVarmam
4.PathaipuVa
Sponsors
Central Council for Research in Siddha
Eligibility
Inclusion criteria
Inclusion criteria: 1. Sex – Both sex 2. Patients with Primary Osteoarthritis - knee joints (single or both knees). 3. Swelling in the Knee Joints 4. Joint stiffness 5. Restricted movements of joints. 6. Crepitus of joints. 7.Patients with WOMAC Score = 25 = 72
Exclusion criteria
Exclusion criteria: 1.Age less than 40 years or more than 60 years. 2.Patients with Diabetes/Hepatic failure/Renal failure. 3.History of bony or soft tissue injury to knee joint/ surgical interventions 4.Patients having Rheumatoid arthritis, Gout, Viral fever (Chikungunya) and Psoriatic arthritis. 5.Patients who are taking any form of steroids.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Safety of the study drug will be assessed by using following parameters: CBC, HB, PCV, LFT, RFT, Diabetic profile, Lipid profile and Urine routine on 0 day and 31st day. 2.Efficacy of the trial drug will be assessed by WOMAC 3.1 INDEX on 0 day, 31st day and 90th day.Timepoint: 0 day - Before inclusion of Trial . 31st day - After Successful completion of Trial. 90th day - Trial Follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in the quality of life of AKV patients will be evaluated through OAKHQOL index on 0 day, 31st day and 90th day.Timepoint: 0 day - Before inclusion of Trial . 31st day - After Successful completion of Trial. 90th day - Trial Follow-up | — |
Countries
India
Contacts
Public ContactDr S Shunmugaram
Siddha Regional Research Institute
Outcome results
None listed